Cardiovascular Effect of Imipramine and Nortriptyline in Elderly Patients

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1981 Jan 1

PMID 6794083

Citations 19

Authors

P Thayssen

M Bjerre

P Kragh-Sorensen

M Moller

O L Petersen

C B Kristensen

L F Gram

Affiliations

Soon will be listed here.

Abstract

Cardiovascular effects in elderly depressed patients (age 62-78 years) treated with imipramine (N = 11) or nortriptyline (N = 10) were recorded by monitoring of heart rate, blood pressure, systolic time intervals, standard ECG and 24-h ECG. The two drugs exhibited distinctly different cardiovascular reactions. The use of imipramine was severely limited by orthostatic hypotension occurring at subtherapeutic plasma levels, which resulted in falls with fracture in two patients. In contrast, nortriptyline at therapeutic drug levels did not significantly influence orthostatic blood pressure regulation. Nortriptyline caused moderate changes in systolic time intervals, indicating impairment in myocardial contractility. This effect was not seen with imipramine, but a majority of the patients did not reach therapeutic plasma levels because of blood pressure reactions. Neither imipramine nor nortriptyline induced changes in cardiac conduction time measurements or arrhythmias. In addition to the blood pressure reactions, the use of imipramine was complicated by dose dependent kinetics.

Citing Articles

Obstructive Sleep Apnea and Smoking Increase the Risk of Cardiovascular Disease: Smoking Cessation Pharmacotherapy.

Pataka A, Kotoulas S, Karkala A, Tzinas A, Kalamaras G, Kasnaki N J Clin Med. 2023; 12(24).

PMID: 38137639 PMC: 10743586. DOI: 10.3390/jcm12247570.

Antidepressant Drugs Effects on Blood Pressure.

Calvi A, Fischetti I, Verzicco I, Belvederi Murri M, Zanetidou S, Volpi R Front Cardiovasc Med. 2021; 8:704281.

PMID: 34414219 PMC: 8370473. DOI: 10.3389/fcvm.2021.704281.

Antidepressants and cardiovascular adverse events: A narrative review.

Nezafati M, Vojdanparast M, Nezafati P ARYA Atheroscler. 2015; 11(5):295-304.

PMID: 26715935 PMC: 4680078.

Serotonin and blood pressure regulation.

Watts S, Morrison S, Davis R, Barman S Pharmacol Rev. 2012; 64(2):359-88.

PMID: 22407614 PMC: 3310484. DOI: 10.1124/pr.111.004697.

Influence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteers.

Jensen B, Roberts R, Vyas R, Bonke G, Jardine D, Begg E Br J Clin Pharmacol. 2011; 73(4):619-28.

PMID: 21999196 PMC: 3376438. DOI: 10.1111/j.1365-2125.2011.04126.x.

References

Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4):278-96. DOI: 10.1111/j.2044-8260.1967.tb00530.x. View

Rasmussen E, Kristjansen P . ECG changes during amitryptiline treatment. Am J Psychiatry. 1963; 119:781-2. DOI: 10.1176/ajp.119.8.781. View

Muller O, Goodman N, Bellet S . The hypotensive effect of imipramine hydrocloride in patients with cardiovascular disease. Clin Pharmacol Ther. 1961; 2:300-7. DOI: 10.1002/cpt196123300. View

Nagy A, Treiber L . Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms. J Pharm Pharmacol. 1973; 25(8):599-603. DOI: 10.1111/j.2042-7158.1973.tb10644.x. View

Kantor S, Glassman A, BIGGER Jr J, Perel J, Giardina E . The cardiac effects of therapeutic plasma concentrations of imipramine. Am J Psychiatry. 1978; 135(5):534-8. DOI: 10.1176/ajp.135.5.534. View

Kragh-Sorensen P, Hansen C, BAASTRUP P, Hvidberg E . Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression. Psychopharmacologia. 1976; 45(3):305-12. DOI: 10.1007/BF00421145. View

Bjerre M, Gram L, Kragh-Sorensen P, Kristensen C, Pedersen O, Moller M . Dose-dependent kinetics of imipramine in elderly patients. Psychopharmacology (Berl). 1981; 75(4):354-7. DOI: 10.1007/BF00435852. View

Kuck K, Hanrath P, Lubda J, Mathey D, BLEIFELD W . [Anti-arrhythmic effect of tocainide (lidocaine congener) on ventricular arrhythmias (author's transl)]. Dtsch Med Wochenschr. 1979; 104(48):1701-5. DOI: 10.1055/s-0028-1129175. View

Kragh-Sorensen P, Larsen N . Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels. Clin Pharmacol Ther. 1980; 28(6):796-803. DOI: 10.1038/clpt.1980.237. View

10.

Gram L, Sondergaard I, Christiansen J, Petersen G, Bech P, REISBY N . Steady-state kinetics of imipramine in patients. Psychopharmacology (Berl). 1977; 54(3):255-61. DOI: 10.1007/BF00426573. View

11.

Glassman A, BIGGER Jr J, Giardina E, Kantor S, Perel J, Davies M . Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet. 1979; 1(8114):468-72. DOI: 10.1016/s0140-6736(79)90824-9. View

12.

WEISSLER A, Harris W, SCHOENFELD C . Bedside technics for the evaluation of ventricular function in man. Am J Cardiol. 1969; 23(4):577-83. DOI: 10.1016/0002-9149(69)90012-5. View

13.

Burgess C, Montgomery S, Wadsworth J, Turner P . Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients. Postgrad Med J. 1979; 55(648):704-8. PMC: 2425751. DOI: 10.1136/pgmj.55.648.704. View

14.

Giardina E, BIGGER Jr J, Glassman A, Perel J, Kantor S . The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation. 1979; 60(5):1045-52. DOI: 10.1161/01.cir.60.5.1045. View

15.

Fenimore D, Meyer C, Davis C, Hsu F, Zlatkis A . High-performance thin-layer chromatographic determination of psychopharmacologic agents in blood serum. J Chromatogr. 1977; 142:399-409. DOI: 10.1016/s0021-9673(01)92053-9. View

16.

Burckhardt D, RAEDER E, Muller V, Imhof P, Neubauer H . Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA. 1978; 239(3):213-6. View

17.

Gram L . Plasma level monitoring of tricyclic antidepressant therapy. Clin Pharmacokinet. 1977; 2(4):237-51. DOI: 10.2165/00003088-197702040-00001. View

18.

Vohra J, Burrows G, Hunt D, SLOMAN G . The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol. 1975; 3(3):219-27. View

19.

Vohra J, Burrows G, SLOMAN G . Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti-depressant drugs. Aust N Z J Med. 1975; 5(1):7-11. DOI: 10.1111/j.1445-5994.1975.tb03247.x. View

20.

IDESTROEM C, CADENIUS B . IMIPRAMINE-DESMETHYLIMIPRAMINE. A PHARMACOLOGICAL STUDY ON HUMAN BEINGS. Psychopharmacologia. 1964; 5:431-9. DOI: 10.1007/BF02193480. View